期刊文献+

MTHFR基因多态性及同型半胱氨酸与青年脑血管病的关系 被引量:5

Genetic Polymorphism of Methylenetetrahydrofolate Redcutase and Homocysteine in Young Adults With Cerebrovascular DiSease
在线阅读 下载PDF
导出
摘要 目的:研究Ns,N10-亚甲基四氢叶酸还原酶(MTHFR)基因多态性及血浆同型半胱氨酸(Hcy)水平与青年脑血管病的关系。方法:研究对比40例青年脑血管病患者(首次发病年龄≤50岁)及32例健康青年人的MTHFR基因多态性及血浆Hcy水平。结果:(1)对照组及病例组T/T纯合子率分别为37.5%和22.5%;T等位基因频率分别为60.9%和51.3%,差异均无显著统计意义(均P>0.05)。(2)病例组血浆Hcy几何均值(11.0±2.3μmol/L)显著高于对照组(8.0±1.4μmol/L,P<0.05)。(3)所有受试者中T/T组Hcy值高于C/C组(10.4μmol/L和7.6μmol/L),但差异无显著性(P>0.05)。结合叶酸考虑,进一步将所有受试者按叶酸中位数水平分组。叶酸中位数以下组中,T/T组Hcy值显著高于C/C组(P<0.05);而叶酸中位数以上组中,T/T组Hcy值与C/C组无显著差异。(4)血浆Hcy与叶酸、维生素B12呈显著负相关,与肌酐呈显著正相关。吸烟者血浆Hcy水平显著高于不吸烟者(P<0.05)。结论:(1)本组人群MTHFR基因C677T突变的纯合子在低叶酸状态下可引起血浆Hcy水平显著增高,但与青年脑血管病无显著关系。MTHFR基因677TT纯合突变可能为健康青年人脑血管的保护因素。(2)血浆Hcy水平与青年脑血管病的发生密切相关。(3)叶酸、维生素B12肌酐、吸烟是Hcy的非遗传影响因素。 Objective: to investigate the relationships of polymrophisms of MTHFR and plasma homocysteine(Hcy) levels with cerebrovascular disease in young adults. Methods: This case control study was based on 40 consecutive patients of young adult cerebrovascular disease (age at first event, ≤ 50 years). 32 age-and sex -matched apparently healthy subjects served as controls. Their polymorphisms of MTHFR gene were analyzed using PCR-RFLP and their fasting plasma total homocysteine(tHcy)levels were measured using FP1A. In addition, serum folate and vitamin B12 of all the subjects were detected. Results: (1) There was no significant difference between patients and control subjects in either TT genotype frequency(22. 5% versus 37. 5%; P>0. 05) or T allele frequency(0. 513 versus 0. 609; centile). (2)Mean total fasting plasma homocysteine concentrations were significantly higher in patients than in the normal subjects(11.0±2. 5μmol/L versus 8. 0±1. 4μmol/L, P<0. 05). (3) There was a positive association between the homozygous(T/T) mutation and elevated fasting plasma homocysteine levels, mainly among those with low serum foiate. In addition, plasm homocysteine level was inversely related to serum folate and vitamin B12 concentrations whereas positively related to serum creatinine and smoking. Conclusions: In this population, MTHFR polymorphism is positively associated with higher homocysteine levels mainly among those with low serum folate level but noft with risk of cerebrovascular diseases in yong a-dult. Indeed, the T allele may in fact protect thd cerebral endothelium in young normal subjects. Elevated plasm homocysteine is strongly associated with an increased prevalence of young cerebrovascular disease. In addition to gene mutation. Plasm homocysteine level is inversely related to serum folate and vitamin B12 concentrations whereas positively related to serum creatinine and smoking.
出处 《脑与神经疾病杂志》 2004年第4期271-274,共4页 Journal of Brain and Nervous Diseases
关键词 脑血管病 基因 同型半胱氨酸 青年 Cerebrovascular disease gene homocystenine youth
  • 相关文献

参考文献16

  • 1Lalouschek W, Aull S, Serles W, et al. Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects. J Lab Clin Med, 1999,133:575~82
  • 2Demuth K, Moatti N, Hanon O, et al. Opposite effects of plasma homocysteine and the methylenetetrahydrofolate reductase C677T mutation on carotid artery geometry in asymptomatic adults. Arterioscler Thromb Vasc Biol, 1998,18:1838~1843
  • 3Buttler R, Morris AD, Struthers AD, et al. The T allele of the C677T 5, 10-methylenetetrahydrofolate reductase(MTHFR) gene polymorphism may protect endothelial function in young, normal subjects. Arterioscler Thromb Vasc Biol, 2002,22:193
  • 4Vitamin Intervention for Stroke Prevention(VISP). Major ongoing stroke trials. Stroke, 2001,32:2456.Abstract
  • 5Kristensen B,Malm J,Carlberg B,et a1.Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in Northern Sweden.Stroke,1997;28:1702-1709
  • 6Madonna P, Stefano V. de, Coppola A, et al. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke.Stroke, 2002,33:51-56
  • 7Hankey GJ, Eikelboom JW, Homocysteine and vascular disease. Lancet, 1999,354:407-413
  • 8VITAmins TO Prevent Stroke(VITATOPS). Major ongoing stroke trials. Stroke, 2001,32:2456-2457.Abstract
  • 9Frosst RBlom HJ,Milos R,et aI.A candidate genetic risk factor for vascular disease:a Common mutation in methylenetrahydrofolate reductase. Nat Genet, 1995,10:111-3
  • 10Graham IM,Daly LE,Refsum HM,et a1.Plasma homocysteine as a risk factor for vascular disease:the European Concerted Action Project.JAm Med Assoc,1997;277:1775-81

同被引文献60

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部